Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Newcomers To White House, FDA Augur Up-Regulation: Top Stories Of 2009

Executive Summary

The prospect of heightened regulation under the Obama administration and a reorganized FDA - in an environment characterized by high pressure from public safety groups - commanded the attention of personal-care interests in 2009
Advertisement

Related Content

Council Celebrating Industry's Contribution To Economy At 2010 Meeting
Study Finding Musks In Newborns Warrants Updated Fragrance Labeling Law - CSC
FDA Releases New Lipstick Lead Data, Putting Names To Numbers
Schakowsky Preps Cosmetics Bill, Spooked By "Scary" Face-Paint Report
Less Tolerant FDA May Flex Enforcement Muscles On Cosmeceuticals - Lawyer
Less Tolerant FDA May Flex Enforcement Muscles On Cosmeceuticals - Lawyer
J&J Singled Out By Safe Cosmetics Campaign For “Toxins” In Baby Care
Cosmetic Substances Found In River Fish Have EPA Expanding Its Investigation
Hamburg/Sharfstein Choice Underscores Public Health, Stricter Oversight
Campaign Finds “Toxins” In Kids’ Bath Products; Democrats Outraged
Advertisement
UsernamePublicRestriction

Register

RS016644

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel